SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.70-0.1%Nov 26 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brian P. who wrote (4253)7/12/1998 10:29:00 AM
From: chukles  Read Replies (1) of 9523
 
If Pfe gets a fast track NDA on Celabra, Merck will have to submit their drug using the normal submission process which puts them in front of the FDA Advisory Panel. That will add a significant amount of time to the approval process. The way FDA paranoia is spreading , my bet would be for a one year review period at a minimum. Either way it will be a great partnership with Monsanto. I'll bet AHP is happy about this.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News